Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM
Mirati Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -4.37 | -2.97 | -2.92 | -3.23 | -5.66 | -5.28 | -6.05 | -9.82 | -28.54 | -12.49 | -16.03 |
PEG Ratio | 0.24 | -4.49 | 0.21 | -0.24 | 2.00 | 0.61 | 0.90 | -0.07 | 0.55 | -0.6 | -0.58 |
PS Ratio | 172.63 | 153.68 | 301.05 | 2.8K | 722.95 | 695.49 | 6.43K | 26.3K | 127.29 | n/a | n/a |
PB Ratio | 2.99 | 2.89 | 2.50 | 2.62 | 3.48 | 3.35 | 3.65 | 5.63 | 8.43 | 7.36 | 6.91 |
P/FCF Ratio | -19.69 | -15.92 | -11.33 | -20.16 | -28.24 | -25.69 | -28.19 | -55.92 | -186.34 | -85.37 | -78 |
P/OCF Ratio | -19.7 | -16.01 | -11.35 | -20.29 | -28.49 | -25.99 | -28.39 | -57 | -194.3 | -89.05 | -78.78 |
OCF/S Ratio | -8.76 | -9.6 | -26.54 | -137.9 | -25.37 | -26.76 | -226.33 | -461.49 | -0.66 | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 |
Quick Ratio | 7.40 | 5.79 | 7.51 | 6.94 | 9.65 | 10.10 | 10.87 | 10.51 | 9.60 | 7.07 | 16.91 |
Current Ratio | 7.54 | 5.85 | 7.54 | 6.96 | 9.65 | 10.10 | 10.87 | 10.50 | 9.60 | 7.07 | 16.91 |
Asset Turnover | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | -44.2 | n/a | n/a | n/a | n/a |
Return on Equity | -0.17 | -0.24 | -0.21 | -0.2 | -0.15 | -0.16 | -0.15 | -0.14 | -0.07 | -0.15 | -0.11 |
Return on Assets | -0.14 | -0.19 | -0.18 | -0.17 | -0.13 | -0.14 | -0.13 | -0.13 | -0.06 | -0.12 | -0.1 |
Return on Invested Capital | -0.17 | -0.24 | -0.2 | -0.2 | -0.16 | -0.15 | -0.15 | -0.14 | -0.07 | -0.14 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.84 | 0.91 | 0.89 | -150.86 | -23.13 | -22.93 | -183.73 | -513.51 | -0.62 | n/a | n/a |
Net Profit Margin | -9.87 | -12.92 | -25.75 | -216.78 | -31.96 | -32.91 | -265.71 | -669.39 | -1.12 | n/a | n/a |
Pretax Profit Margin | -9.87 | -12.92 | -25.75 | -216.51 | -31.91 | -32.91 | -265.71 | -667.63 | -1.07 | n/a | n/a |
Operating Profit Margin | -10.49 | -13.68 | -27.04 | -226.68 | -34.33 | -33.05 | -259.83 | -659.11 | -1.11 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -10.42 | -13.6 | -26.89 | -225.73 | -34.2 | -32.92 | -258.94 | -659.11 | -1.1 | n/a | n/a |